Not Signed In -
Caffeine |
|
|
This article is about the chemical substance caffeine. For other uses, see Caffeine (disambiguation). Caffeine General Systematic name 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione Other names 1,3,7-trimethylxanthine trimethylxanthine theine mateine guaranine methyltheobromine Molecular formula C8H10N4O2 SMILES O=C1C2=C(N=CN2C)N(C(=O)N1C)C Molar mass 194.19 g/mol Appearance Odorless, white needles or powder CAS number [58-08-2] Properties Density and phase 1.2 g/cm3, ...
Wikipedia - [full article]
Caffeine Clinical Trials
- Assessment and Treatment of Caffeine Dependence
ClinicalTrials.gov Identifier: NCT00338195 - Recruiting
Self-Identified Problematic Caffeine Use; DSM-IV Substance Dependence as Applied to Caffeine
- Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
ClinicalTrials.gov Identifier: NCT00205166 - Recruiting
Coronary Artery Disease
- Dextro-Amphetamine Versus Caffeine in Treatment-Resistant OCD
ClinicalTrials.gov Identifier: NCT00363298 - Recruiting
Obsessive-Compulsive Disorder
- Caffeine for Apnea of Prematurity (CAP)
ClinicalTrials.gov Identifier: NCT00182312 - Active, not recruiting
Apnea of Prematurity
- Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients
ClinicalTrials.gov Identifier: NCT00495092 - Recruiting
Cocaine Related Disorders
- The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease
ClinicalTrials.gov Identifier: NCT00564824 - Recruiting
Coronary Disease
- Coronary Care Caffeine
ClinicalTrials.gov Identifier: NCT00137098 - Completed
Myocardial Infarction
- The Effect of Caffeine on Ischemic Preconditioning
ClinicalTrials.gov Identifier: NCT00184912 - Completed
Caffeine; Ischemic Preconditioning; Ischemia-Reperfusion Injury
- Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
ClinicalTrials.gov Identifier: NCT00471952 - Recruiting
Migraine With Aura; Migraine Without Aura
- Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
ClinicalTrials.gov Identifier: NCT00457652 - Recruiting
Ischemia Reperfusion Injury
- Does Caffeine Help Children With Obstructive Sleep Apnea Recover Faster From Anesthesia and With Less Complication After Tonsillectomy and Adenoidectomy?
ClinicalTrials.gov Identifier: NCT00273754 - Recruiting
Sleep Apnea, Obstructive; Tonsillectomy and Adenoidectomy; Postoperative Complications
- Caffeine and Intermittent Claudication
ClinicalTrials.gov Identifier: NCT00388128 - Recruiting
Intermittent Claudication
- Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence
ClinicalTrials.gov Identifier: NCT00495183 - Not yet recruiting
Cocaine Dependence
- The Effect of Caffeine in Elderly Citizens
ClinicalTrials.gov Identifier: NCT00117520 - Completed
Healthy elderly citizens
- Caffeine in the Prevention of Post-Operative Nausea and Vomiting
ClinicalTrials.gov Identifier: NCT00130026 - Completed
POSTOP NAUSEA VOMITING
- Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00459420 - Recruiting
Parkinson's Disease; Excessive Daytime Somnolence
- Experimental Studies of the Effects of Caffeine on Glucose Regulation
ClinicalTrials.gov Identifier: NCT00432887 - Completed
Diabetes Mellitus, Type 2
- Effects of Low Doses of Caffeine on Mood, Physiology and Mental Function
ClinicalTrials.gov Identifier: NCT00487227 - Completed
Healthy
- Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan
ClinicalTrials.gov Identifier: NCT00009542 - Completed
Healthy
- Determining the Risk Factors such as Smoking, Alcohol, and Caffeine and their Association with Osteoporosis in Men
ClinicalTrials.gov Identifier: NCT00011323 - Completed
Osteoporosis
- Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
ClinicalTrials.gov Identifier: NCT00430170 - Completed
Cardiovascular Disease; Ischemia-Reperfusion Injury
- Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia
ClinicalTrials.gov Identifier: NCT00253929 - Completed
Blood Flow in Healthy Volunteers
- Metabolic Capacity of Israeli Populations
ClinicalTrials.gov Identifier: NCT00162383 - Terminated
Healthy volunteers
email this page
print this page
bookmark this page
feedback on this page
